False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus: A rebuttal

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 6, 2010, Pages 1439-1441

  Alpert, D R ^a   Salmon, J E ^b  

^a JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M;

ANTIPHOSPHOLIPID SYNDROME; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; HUMAN; LETTER; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; COHORT STUDIES; FALSE POSITIVE REACTIONS; HEPARIN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; THROMBOCYTOPENIA;

EID: 77954497952     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03866.x     Document Type: Letter

References (15)

1. Pauzner R, Greinacher A, Selleng K, Althaus K, Shenkman B, Seligsohn U. False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost 2009, 7:1070-4.
2. Warkentin TE. Antiphospholipid and anti-PF4 antibodies: an association affecting anti-PF4/heparin assay analysis. J Thromb Haemost 2009, 7:1067-9.
3. Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Ann Rheum Dis 2008, 67:395-401.
4. Alpert DR, Erkan D, Mandl LA, Yin W, Peerschke EI, Roubey RAS, Salmon JE. Increased prevalence of anti-heparin platelet factor 4 antibodies in antiphospholipid antibody-positive patients without systemic lupus erythematosus. Arthritis Rheum 2007, 56:4239-40.
5. Bourhim M, Darnige L, Legallais C, Arvieux J, Cevallos R, Pouplard C, Vijayalakshmi MA. Anti-beta2-glycoprotein I antibodies recognizing platelet factor 4-heparin complex in antiphospholipid syndrome in patient substantiated with mouse model. J Mol Recognit 2003, 16:125-30.
6. de Larranaga G, Martinuzzo M, Bocassi A, Fressart MM, Forastiero R. Heparin-platelet factor 4 induced antibodies in patients with either autoimmune or alloimmune antiphospholipid antibodies. Thromb Haemost 2002, 88:371-3.
7. Lasne D, Saffroy R, Bachelot C, Vincenot A, Rendu F, Papo T, Aiach M, Piette JC. Tests for heparin-induced thrombocytopenia in primary antiphospholipid syndrome. Br J Haematol 1997, 97:939.
8. Martin-Toutain I, Piette J, Diemert M, Faucher C, Jobic L, Ankri A. High prevalence of antibodies to platelet factor 4 heparin in patients with antiphospholipid antibodies in absence of heparin-induced thrombocytopenia. Lupus 2007, 16:79-83.
9. Martinuzzo ME, Forastiero RR, Adamczuk Y, Pombo G, Carreras LO. Antiplatelet factor 4-heparin antibodies in patients with antiphospholipid antibodies. Thromb Res 1999, 95:271-9.
10. Erkan D, Derksen WJ, Kaplan V, Sammaritano L, Pierangeli SS, Roubey R, Lockshin MD. Real world experience with antiphospholipid antibody tests: how stable are results over time? Ann Rheum Dis 2005, 64:1321-5.
11. Walenga JM, Jeske WP, Prechel MM, Bakhos M. Newer insights on the mechanism of heparin-induced thrombocytopenia. Semin Thromb Hemost 2004, 30:57-67.
12. Warkentin TE, Sheppard JI. No significant improvement in diagnostic specificity of an anti-PF4/polyanion immunoassay with use of high heparin confirmatory procedure. J Thromb Haemost 2006, 4:281-2.
13. Whitlatch NL, Perry SL, Ortel TL. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 2008, 100:678-84.
14. Package Insert, "PF4 Enhanced® GTI, Waukesha, WI, 28 June 2007
15. Warkentin TE, Makris M, Jay RM, Kelton JG. A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia. Am J Med 2008, 121:632-6.